IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Atlas Venture Associates IX, LLC

Q4 2019 Holdings

Filed 2020-02-11 | 6 holdings | $57.4K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Intellia Therapeutics Inc(NTLA)COM45826J105$23.7K1,615,32141.3%
Spero Therapeutics Inc(SPRO)COM84833T103$13.2K1,376,96823.1%
Surface Oncology IncCOM86877M209$8.7K4,645,45315.2%
Synlogic IncCOM87166L100$6.8K2,651,96311.9%
Snap Inc(SNAP)CL A83304A106$2.5K150,1604.3%
Unum Therapeutics IncCOM903214104$2.4K3,361,5354.2%